4-Bromo-2-fluoro-1-(methylsulfonyl)benzene – (648904-84-1)

DL-Norleucine, 616-06-8, 2-Aminohexanoic acid, H-DL-Nle-OH, Norleucine, DL-, (+/-)-Norleucine, Hexanoic acid, amino-, Norleucine, (+/-)-, (+-)-Norleucine, 2-Aminohexanoic acid, dl-, 5C81BE5GKK, MFCD00064422, DL-.alpha.-Aminocaproic acid, EINECS 210-462-7, NSC 203799, NSC-203799, DTXSID40861874, NSC74430, NSC203799, Hexanoic acid, (S)-, .alpha.-Aminocaproic acid, DL-2-Aminohexanoic Acid, DL-alpha-Aminocaproic acid, UNII-5C81BE5GKK, 2-Aminohexanoicacid, (.+-.)-Norleucine, NORLEUCINE, (L), (.+/-.)-Norleucine, SCHEMBL8392, (+/-)-2-Aminocaproic acid, NORLEUCINE DL-FORM [MI], CHEBI:36405, DTXCID90810731, 496-90-2, NSC10378, BBL011583, NSC-74430, STK943761, AKOS000201118, AKOS016053503, CS-W013425, FN09068, HY-W012709, SB75379, AS-17286, DA-53909, SY036145, SY038236, SY062052, DB-048259, N0302, NS00015352, EN300-18344, (+/-)-2-Aminocaproic acid, 2-Aminohexanoic acid, Q27116817, Z57127434, F2191-0205, 0FF7D875-44F8-41FA-8C5A-94108672BD95, 210-462-7